/Investor DB

Pivotal Life Sciences — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Oculisoculis.cominSeries B · Jan 2018 · $21M

Oculis is a biopharmaceutical company developing pharmaceutical drug products, with a focus on ophthalmic and eye disease treatments.

BiotechHealthtechMedical DevicesBoston, CH

Riad Sherif(Chief Executive Officer)inRiad Sherif, M.D.(Chief Executive Officer)

Co-investorsBay City CapitalBrunnur Ventures GPVI PartnersBVCF

Windwardwindward.aiin𝕏Jun 2018

Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.

AI & Machine LearningData & InfrastructureDefense TechTel Aviv

Amiad Daniel(Executive Officer, Director)Matan Peled(Founder)inAmi Daniel(Founder)

BoardDov Gatmon(Director)Patrick Poon(Director)Eden Shochat(Director)in

Co-investorsAlephFTV CapitalThompson Hutton, LLCJanus Henderson InvestorsQiming Venture PartnersQuan Capital+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.